Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol gets U.S. subpoena on Abilify marketing
Reuters
Saturday, February 18, 2012 - 12:36pm
tags:
Bristol-Myers Squibb, Abilify
J&J Recalls Infant Tylenol
Barron's
Saturday, February 18, 2012 - 12:31pm
tags:
JNJ, Tylenol, recalls
Who Doubts The USB Thumb Drive Sequencer? A Rival
Forbes
Saturday, February 18, 2012 - 12:25pm
tags:
Oxford Nanopore, MinIon, DNA sequencing, Ion Torrent, Life Technologies
Corcept Therapeutics Incorporated Announces FDA Approval of Korlym(TM) (Mifepristone): First and Only Approved Medication for Cushing's Syndrome Patients
Yahoo/MarketWire
Saturday, February 18, 2012 - 12:21pm
tags:
Corcept Therapeutics, Korlym, Cushing's syndrome
BioTime CEO Michael D. West to Present at New York Stem Cell Summit
Yahoo/BusinessWire
Saturday, February 18, 2012 - 12:14pm
tags:
BioTime
Big Pharma's Newest Interest
Motley Fool
Saturday, February 18, 2012 - 12:12pm
tags:
hepatitis C
No Way? Obesity Drugs Have Side Effects
Motley Fool
Saturday, February 18, 2012 - 12:11pm
tags:
Vivus, obesity, Qnexa, Orexigen, Contrave, Arena Pharmaceuticals
Gilead Remains Neutral
Yahoo/Zacks
Saturday, February 18, 2012 - 12:07pm
tags:
Gilead Sciences
The Next DNA Disruptor?
Forbes
Saturday, February 18, 2012 - 11:59am
tags:
Oxford Nanopore, DNA sequencing, Illumina, Complete Genomics, Life Technologies, Pacific Biosciences
Pfizer grabs leg up in pursuit of rare disease drug win
Fierce Biotech
Friday, February 17, 2012 - 1:19pm
tags:
Pfizer, transthyretin familial amyloid polyneuropathy, tafamidis meglumine, fast track
Achillion, Vertex rally on Gilead's woes
Marketwatch
Friday, February 17, 2012 - 1:17pm
tags:
Vertex, Gilead, Achillion, GS-7977, protease inhibitors, hepatitis C
Dendreon: Overall Survival Data For Provenge From 2012 GU Poster
Seeking Alpha
Friday, February 17, 2012 - 1:15pm
tags:
Dendreon, prostate cancer, Provenge
EU suggests new approval for diabetes drug Byetta
Yahoo/AP
Friday, February 17, 2012 - 1:14pm
tags:
Europe, diabetes, Byetta, Amylin, Eli Lilly
A Hidden Reason Forest Laboratories' Future Looks Bright
Motley Fool
Friday, February 17, 2012 - 1:13pm
tags:
Forest Labs
Bristol gets U.S. subpoena on Abilify marketing
Reuters
Friday, February 17, 2012 - 1:11pm
tags:
Abilify, Bristol-Myers Squibb, depression, schizophrenia
Vivus obesity drug has safety risks-US FDA staff
Reuters
Friday, February 17, 2012 - 9:12am
tags:
Vivus, obesity, FDA, Qnexa
How the medical industry is using (and could use): Pinterest
Med City News
Friday, February 17, 2012 - 9:10am
tags:
social media, Pinterest
California Supreme Court to hear pay-for-delay case v. Bayer
Reuters
Friday, February 17, 2012 - 9:09am
tags:
California, pay-for-delay, Bayer, generics, Cipro
Microchip Implant Makes Remote-Controlled Drug Delivery Possible
Bloomberg
Friday, February 17, 2012 - 9:08am
tags:
drug delivery, microchip implants, Forteo, Eli Lilly, generics, MicroCHIPS
Novartis to Add Warnings to Rasilez Blood-Pressure Drug
Bloomberg
Friday, February 17, 2012 - 9:06am
tags:
Novartis, Rasilez, Europe, warnings, Tekturna

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.